1.
Mudzviti T, Sibanda M, Gavi S, Maponga CC, Morse GD (2012) Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program. J Infect Dev Ctries 6:806–808. doi: 10.3855/jidc.1908